Myung-Ju Ahn

发表

JuLI: accurate detection of DNA fusions in clinical sequencing for precision oncology.

Joon Seol Bae, Ki-Wook Lee, Hyun-Tae Shin, 2019, The Journal of molecular diagnostics : JMD.

Prevalence and detection of low-allele-fraction variants in clinical cancer samples

Woo Yong Lee, Kyunghee Park, Kyoung-Mee Kim, 2017, Nature Communications.

Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal Cancer

Jeon Yeob Jang, Sang Gyu Park, Joon Young Choi, 2009, Clinical Cancer Research.

Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial.

You Lu, Haiyi Jiang, Kazuhiko Nakagawa, 2015, The Lancet. Oncology.

Comparative effectiveness of bevacizumab plus cisplatin‐based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non‐squamous non‐small cell lung cancer patients applying real‐life outcomes

Stefan Walzer, Myung-Ju Ahn, M. Ahn, 2011, Asia-Pacific journal of clinical oncology.

Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study.

Charu Aggarwal, Myung-Ju Ahn, Edward B Garon, 2019, The Lancet. Respiratory medicine.

Volume-based assessment by 18F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer

Joon Young Choi, Young Mog Shim, Yong Chan Ahn, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Michael Thomas, Takashi Seto, Kazuhiko Nakagawa, 2013, The New England journal of medicine.

Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study

Kyung Soo Lee, Myung-Ju Ahn, Ho Yun Lee, 2016, Cancer Imaging.

New CT response criteria in non-small cell lung cancer: proposal and application in EGFR tyrosine kinase inhibitor therapy.

Kyung Soo Lee, Chin A Yi, Myung Jin Chung, 2011, Lung cancer.

Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications

Kyung Soo Lee, Chin A Yi, Myung Jin Chung, 2010, Annals of Surgical Oncology.

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Jianying Zhou, Erdem Goker, Jun Zhao, 2019, The Lancet.

Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component.

Chia-Chi Lin, Tomonori Hirashima, Helen Mann, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Blood Droplet-Based Cancer Diagnosis via Proteolytic Activity Measurement in Cancer Progression

Gyudo Lee, Kilho Eom, Heung Jae Park, 2017, Theranostics.

Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study).

Myung-Ju Ahn, Hyun Ae Jung, J. Ahn, 2020, Lung cancer.

Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases.

Lucio Crinò, Benjamin Solomon, Patrick Schnell, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.

Ki-Hwan Lee, Dong-Hyun Yu, Joon-Ik Ahn, 2002, Biochemical and biophysical research communications.

Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy?

Jae-Hun Kim, Kyung Soo Lee, Yoon-La Choi, 2014, PloS one.

SIDR: simultaneous isolation and parallel sequencing of genomic DNA and total RNA from single cells

Je-Gun Joung, Hui-Sung Moon, Chang Eun Yoo, 2018, Genome research.

DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load

Jung Kyoon Choi, Manel Esteller, Myung-Ju Ahn, 2019, Nature Communications.

Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ

Seung Won Shin, Soong Ho Um, Yong Taik Lim, 2017, Scientific Reports.

cDNA microarray analysis of differential gene expression in gastric cancer cells sensitive and resistant to 5-fluorouracil and cisplatin.

Ki-Hwan Lee, Dong-Hyun Yu, Joon-Ik Ahn, 2005, Cancer research and treatment : official journal of Korean Cancer Association.

Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years.

Kyung Soo Lee, Myung-Ju Ahn, Ho Yun Lee, 2010, Lung cancer.